Latest filing published 02 Sept 2026 for BIOMERIEUX. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Guillaume Bouhours (chief executive) discloses dealings in Biomerieux to AMF. We count 8 filings; the first trade dates from 26 February 2022 and the latest from 31 August 2026.
Market trades split into 4 purchases (€25k) and 1 sale (€299k). No amount is published for 3 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants. Since January 2026: 1 purchase and no sales on the market.
The latest filing, published on 2 September 2026, reports an open-market purchase in Biomerieux. The median gap between a trade and its publication by AMF is 2 days. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from AMF disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations